Cancer Policy Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad July 25, 2025Vol.51 No.29By Claire Marie Porter
Cancer Policy The effects of NIH, FDA cuts will be felt for decades, CBO report estimates July 25, 2025Vol.51 No.29By Paul Goldberg
Cancer Policy COI statement prohibits “unseemly advocacy,” “undue influence” by industry rep on ODAC July 25, 2025Vol.51 No.29By Paul Goldberg
Cancer Policy Columbia settles with Trump, agreeing to a $200M fine, as Harvard fights on July 25, 2025Vol.51 No.29By Claire Marie Porter and Jacquelyn Cobb
In Brief Six researchers awarded $5.3M for pancreatic cancer research by Stephenson Global July 25, 2025Vol.51 No.29
In Brief Dispatch Bio aims to deliver universal treatment across solid tumors with novel immunotherapy approach July 25, 2025Vol.51 No.29
In Brief Research!America President & CEO Mary Woolley to step down in early 2026 July 25, 2025Vol.51 No.29
In Brief Weill Cancer Hub West secures $200M to support launch of UCSF-Stanford collaboration July 25, 2025Vol.51 No.29
In Brief Sharad Goyal and Christina Puchalski receive endowed professorships at George Washington University Cancer Center July 25, 2025Vol.51 No.29